Alpha 2.0
Login Register
» Authors » Finbar Slevin

Finbar Slevin

Explore the profile of Finbar Slevin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 59
Followers 0
Related Specialties
Oncology
Radiology
General Medicine
Top 10 Co-Authors
Ann M Henry
John Lilley
Louise Murray
Sarah Brown
Bashar Al-Qaisieh
Joshua Mason
David Bottomley
Jonathan Smith
Matthew Lowe
Louise J Murray
Published In
Clin Transl Radiat Oncol
BMJ Open
Radiother Oncol
Int J Surg Pathol
Med Dosim
Affiliations
Soon will be listed here.
Recent Articles
1.
APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trial
Slevin F, Hudson E, Boele F, Powell J, Noutch S, Borland M, et al.
BMJ Open . 2025 Feb; 15(2):e097810. PMID: 40010843
Introduction: Oligodendroglioma (ODG) is a rare type of brain tumour, typically diagnosed in younger adults and associated with prolonged survival following treatment. The current standard of care is maximal safe...
2.
Multidimensional fatigue and its impact on work productivity, mood and quality of life in long-term survivors following definitive intensity-modulated radiotherapy for oropharyngeal cancer: A cross-sectional study
Iyizoba-Ebozue Z, Nicklin E, Currie S, Price J, Baldwin J, Prestwich R, et al.
J Cancer Surviv . 2025 Jan; PMID: 39825989
Purpose: Radiotherapy (RT) for oropharyngeal cancer (OPC) can lead to late toxicity. Fatigue is a known debilitating issue for many cancer survivors, yet prevalence and severity of long-term fatigue in...
3.
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trial
Slevin F, Alexander S, Brown S, Carter M, Choudhury A, Clipson A, et al.
BMJ Open . 2024 Dec; 14(12):e095560. PMID: 39725427
Introduction: Prostate cancer (PCa) is the most common cancer in men. Recurrence may occur in up to half of patients initially treated with curative intent for high-risk localised/locally advanced PCa....
4.
"Why am I still suffering?": Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapy
Iyizoba-Ebozue Z, Nicklin E, Price J, Prestwich R, Brown S, Hall E, et al.
Tech Innov Patient Support Radiat Oncol . 2024 Mar; 30:100241. PMID: 38510557
Background: Late effects of cancer treatment, such as neurocognitive deficits and fatigue, can be debilitating. Other than head and neck-specific functional deficits such as impairments in swallowing and speech, little...
5.
Brain Re-Irradiation Or Chemotherapy: a phase II randomised trial of re-irradiation and chemotherapy in patients with recurrent glioblastoma (BRIOChe) - protocol for a multi-centre open-label randomised trial
Hudson E, Noutch S, Webster J, Brown S, Boele F, Al-Salihi O, et al.
BMJ Open . 2024 Mar; 14(3):e078926. PMID: 38458809
Introduction: Glioblastoma (GBM) is the most common adult primary malignant brain tumour. The condition is incurable and, despite aggressive treatment at first presentation, almost all tumours recur after a median...
6.
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate Cancer
Slevin F, Zattoni F, Checcucci E, Cumberbatch M, Nacchia A, Cornford P, et al.
Eur Urol Oncol . 2023 Dec; 7(4):677-696. PMID: 38151440
Context: The optimum use of brachytherapy (BT) combined with external beam radiotherapy (EBRT) for localised/locally advanced prostate cancer (PCa) remains uncertain. Objective: To perform a systematic review to determine the...
7.
Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic review
Iyizoba-Ebozue Z, Prestwich R, Brown S, Hall E, Lilley J, Lowe M, et al.
Radiother Oncol . 2023 Aug; 188:109863. PMID: 37619657
When radiotherapy is used in the treatment of head and neck cancers, the brain commonly receives incidental doses of radiotherapy with potential for neurocognitive changes and subsequent impact on quality...
8.
Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review
Zhong J, Slevin F, Scarsbrook A, Serra M, Choudhury A, Hoskin P, et al.
Front Oncol . 2021 Sep; 11:681448. PMID: 34568012
Background: Reirradiation using brachytherapy (BT) and external beam radiation therapy (EBRT) are salvage strategies with locally radiorecurrent prostate cancer. This systematic review describes the oncologic and toxicity outcomes for salvage...
9.
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation
Slevin F, Aitken K, Alongi F, Arcangeli S, Chadwick E, Chang A, et al.
Radiother Oncol . 2021 Sep; 164:104-114. PMID: 34560186
Introduction: Stereotactic Ablative Radiotherapy (SABR) is increasingly used to treat metastatic oligorecurrence and locoregional recurrences but limited evidence/guidance exists in the setting of pelvic re-irradiation. An international Delphi study was...
10.
A feasibility study of hyoscine butylbromide (buscopan) to improve image quality of cone beam computed tomography during abdominal/pelvic Stereotactic Ablative Radiotherapy
Slevin F, Beasley M, Zhong J, Hudson E, Speight R, Lilley J, et al.
BJR Open . 2021 Aug; 3(1):20210045. PMID: 34381954
Objectives: Cone beam computed tomography (CBCT) is used for image guidance of stereotactic ablative radiotherapy (SABR), but it is susceptible to bowel motion artefacts. This trial evaluated the impact of...